Pfizer Limited
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.It is the 3rd largest multinational pharmaceutical company in India.
What Pfizer files
- Others50
- Important12
- Board Meeting10
- Updates2
- Results2
- Dividend/Bonus1
Pfizer has announced its 75th Annual General Meeting. The Annual Report for FY26 is now accessible, and the company declared a final dividend of Rs. 75 per equity share.
Pfizer India inks exclusive 5-year supply & marketing deal with Cipla for Corex Dx, Corex LS, Dolonex, and Neksium. This partnership leverages Cipla's vast network to boost market reach and patient access for these key brands across India.
Pfizer has launched its new 20-valent Pneumococcal Conjugate Vaccine (PCV20) for adults in India. This next-generation, single-dose vaccine offers broad protection against 20 serotypes of pneumococcal disease, surpassing coverage of previous conjugate vaccines in India. This is a crucial development for adults, particularly those with chronic health conditions, aiming to...
Pfizer Limited has announced a board meeting to approve the financial results for the quarter and half-year. Shareholders have been provided a weblink to access the Annual Report for FY 2024-25. The company is facilitating virtual participation in the 74th Annual General Meeting via video conferencing, emphasizing mandatory email ID...
Pfizer Limited has completed the transfer and assignment of its unexpired leasehold rights in approximately 82,000 sq. mtrs. of land at Trans Thane Creek Industrial Area, Turbhe, Thane, along with buildings totaling around 16,494.33 sq. mtrs., to Zoetis Pharmaceutical Research Private Limited. The transaction, effective as of March 29, 2025,...